Topic · page 42 of 47

Lupus & antiphospholipid syndrome

Systemic and cutaneous lupus erythematosus, lupus nephritis, neuropsychiatric lupus, disease activity, remission and low disease activity, damage, antimalarials and targeted treatment; antiphospholipid antibodies and antiphospholipid syndrome, thrombotic and obstetric

Briefs 1,641–1,680 of 1,848 placed here, newest publication first

Briefs in Lupus & antiphospholipid syndrome

Newest publication first

Rheumatology (Oxford)17 Mar 2023
Prevalence and clinical associations of ultrasound-confirmed enthesitis in systemic lupus erythematosus
Cohort study
Lupus15 Mar 2023
An ecological approach to understanding and addressing health inequities of systemic lupus erythematosus
Research article
Rheumatology (Oxford)14 Mar 2023
Genetics of longitudinal kidney function in children and adults with systemic lupus erythematosus
Cohort study
Lupus14 Mar 2023
Predictors of severe hemolytic anemia and its impact on major outcomes in systemic lupus erythematosus: Data from a multiethnic Latin American cohort
Cohort study
Lupus14 Mar 2023
Disrupted resting-state brain functional network properties in non-neuropsychiatric systemic lupus erythematosus patients
Cross-sectional study
Arthritis Rheumatol14 Mar 2023
Platelet LGALS3BP as a Mediator of Myeloid Inflammation in Systemic Lupus Erythematosus
Mechanistic study
RMD Open9 Mar 2023
Identifying high-risk profile in primary antiphospholipid syndrome through cluster analysis: French multicentric cohort study
Cohort study
Lupus8 Mar 2023
Pregnancy outcomes among Egyptian women with systemic lupus erythematosus: A prospective cohort study
Cohort study
RMD Open8 Mar 2023
Risk of COVID-19 among unvaccinated and vaccinated patients with systemic lupus erythematosus: a general population study
Cohort study
Arthritis Care Res (Hoboken)8 Mar 2023
Associations of Postdischarge Follow‐Up With Acute Care and Mortality in Lupus: A Medicare Cohort Study
Cohort study
Lupus6 Mar 2023
KLRG1 is reduced on NK cells in SLE patients, inversely correlates with disease activity and is modulated by hydroxychloroquine in vitro
Mechanistic study
Arthritis Rheumatol6 Mar 2023
A Flare Risk Index Informed by Select Immune Mediators in Systemic Lupus Erythematosus
Diagnostic or prognostic study
Pediatr Rheumatol Online J4 Mar 2023
Maternal and infant outcomes of pregnancy associated with anti-SSA/RO antibodies: a systematic review and meta-analysis
Meta-analysis
Arthritis Care Res (Hoboken)4 Mar 2023
Pregnancy Outcomes in Patients With Interstitial Lung Disease
Cohort study
Lupus3 Mar 2023
The impact of curcumin supplementation on systemic lupus erythematosus and lupus nephritis: A systematic review
Meta-analysis
Lupus Sci Med3 Mar 2023
Generic and disease-adapted cardiovascular risk scores as predictors of atherosclerosis progression in SLE
Diagnostic or prognostic study
Lupus1 Mar 2023
Risk of Bloodstream Infection in Patients with Systemic Lupus Erythematosus Exposed to Prolonged Medium-to-High-Dose Glucocorticoids
Cohort study
Arthritis Care Res (Hoboken)1 Mar 2023
Effect of Systemic Lupus Erythematosus and Immunosuppressive Agents on COVID‐19 Vaccination Antibody Response
Cohort study
Lupus Sci Med28 Feb 2023
Clinical associations of cognitive dysfunction in systemic lupus erythematosus
Cross-sectional study
Rheumatology (Oxford)28 Feb 2023
Reduced homovanillic acid, SDF-1α and SCGF-β levels in cerebrospinal fluid are related to depressive states in systemic lupus erythematosus
Cohort study
Rheumatology (Oxford)27 Feb 2023
Predictors of flare in SLE patients fulfilling lupus low disease activity state: a cohort study of 292 patients with 36-month follow-up
Cohort study
Lancet24 Feb 2023
Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-II)
Randomized controlled trial
Lancet24 Feb 2023
Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-I)
Randomized controlled trial
Lupus24 Feb 2023
Estimating glucocorticoid-related morbidity in lupus nephritis using the glucocorticoid toxicity index
Cohort study
Arthritis Care Res (Hoboken)23 Feb 2023
Assessing the Costs of Neuropsychiatric Disease in the Systemic Lupus International Collaborating Clinics Cohort Using Multistate Modeling
Cohort study
Arthritis Care Res (Hoboken)23 Feb 2023
Association of Ultraviolet B Radiation and Risk of Systemic Lupus Erythematosus Among Women in the Nurses’ Health Studies
Cohort study
Rheumatology (Oxford)22 Feb 2023
Anti-dsDNA IgE induces IL-4 production from basophils, potentially involved in B-cell differentiation in systemic lupus erythematosus
Mechanistic study
Lupus21 Feb 2023
Association of alcohol consumption and fatigue in SLE: A cross-sectional study from Lupus Registry of Nationwide Institution (LUNA) cohort
Cross-sectional study
Lupus20 Feb 2023
Telehealth-supervised exercise in systemic lupus erythematosus: A pilot study
Randomized controlled trial
Arthritis Res Ther17 Feb 2023
Relationship of systemic type I interferon activity with clinical phenotypes, disease activity, and damage accrual in systemic lupus erythematosus in treatment-naive patients: a retrospective longitudinal analysis
Cohort study
Lupus Sci Med14 Feb 2023
Risks of mortality and severe coronavirus disease 19 (COVID-19) outcomes in patients with or without systemic lupus erythematosus
Cohort study
Lupus Sci Med14 Feb 2023
A better self-efficacy is predictive of better health-related quality of life (HRQoL) in patients with systemic lupus erythematosus: data from the Almenara Lupus Cohort
Cohort study
Lupus Sci Med14 Feb 2023
Meeting report: the ALPHA project: a stakeholder meeting on lupus clinical trial outcome measures and the patient perspective
Research article
Arthritis Care Res (Hoboken)12 Feb 2023
Update on the Efficacy and Safety Profile of Voclosporin: An Integrated Analysis of Clinical Trials in Lupus Nephritis
Randomized controlled trial
RMD Open9 Feb 2023
Lipid management in systemic lupus erythematosus according to risk classifiers suggested by the European Society of Cardiology and disease-related risk factors reported by the EULAR recommendations
Cross-sectional study
Arthritis Res Ther9 Feb 2023
Hashimoto’s thyroiditis increases the risk of new-onset systemic lupus erythematosus: a nationwide population-based cohort study
Cohort study
Arthritis Rheumatol8 Feb 2023
Integrative Functional Genomics Identifies Systemic Lupus Erythematosus Causal Genetic Variant in the IRF5 Risk Locus
Mechanistic study
Lupus7 Feb 2023
Dietary patterns and life-styles of patients with gastrointestinal involvement of systemic lupus erythematosus: Questionnaire survey from a tertiary center of China
Cross-sectional study
Lupus4 Feb 2023
Cortical thickness and diffusion tensor imaging in patients with neuropsychiatric systemic lupus erythematosus, with normal structure on brain MRI
Cross-sectional study
Lupus Sci Med3 Feb 2023
Clinical outcome in patients with suspected inflammatory neuropsychiatric lupus treated with immunosuppression: an observational cohort study
Cohort study

All 1,848 Briefs in ExploreShowing Briefs 1,641–1,680 of 1,848, newest first